Guanfacine (Intuniv XR)

Guanfacine is a non-stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD). Unlike amphetamine or methylphenidate, guanfacine does not primarily increase dopamine or norepinephrine concentrations. Instead, it directly stimulates a particular type of norepinephrine receptor: Alpha-2A Adrenergic Receptor — α2A

In Canada, Intuniv XR is marketed as an extended-release tablet in 1 mg, 2 mg, 3 mg and 4 mg strengths. Generic extended-release guanfacine products are also marketed, including APO-Guanfacine XR, JAMP Guanfacine XR and newer generic products.

This fact sheet focuses on extended-release guanfacine used for ADHD.

What You Need to Know

Guanfacine is a: Selective α2A-adrenergic receptor agonist and: Non-stimulant ADHD medication.

It is used to improve symptoms such as:

• Inattention

• Impulsivity

• Hyperactivity

• Difficulty regulating behaviour

• Difficulty sustaining attention

• Emotional over-reactivity in some patients Guanfacine is particularly interesting because norepinephrine plays an important role in the prefrontal cortex, the part of the brain involved in:

• Attention

• Working memory

• Planning

• Impulse control

• Emotional regulation

• Decision-making

• Executive function Guanfacine binds preferentially to α2A receptors; the Canadian product monograph reports approximately 15–20 times greater affinity for α2A than α2B or α2C receptors. The exact mechanism responsible for its clinical ADHD effect is still not completely established.

A simplified pathway is:

1. Guanfacine
2. Stimulates α2A adrenergic receptors
3. Norepinephrine-related signaling in the prefrontal cortex is modified
4. Prefrontal networks involved in attention and behavioural control may function more effectively
5. Attention, impulse control and hyperactivity may improve

What Is Guanfacine Used For?

In Canada, Intuniv XR is approved for ADHD in children and adolescents 6–17 years of age.

It can be used: By itself — monotherapy

or:

Together with a psychostimulant when clinically appropriate.

Examples of stimulants that may be combined with guanfacine include:

• Methylphenidate
• Lisdexamfetamine
• Amphetamine-based ADHD medications Canadian approval does not currently include adult ADHD, so use in adults would be off-label in Canada.

Is Guanfacine a Stimulant?

No.

Guanfacine is not a central nervous system stimulant and is not a controlled stimulant medication.

It works very differently from:

Amphetamine- which increases dopamine and norepinephrine availability,

and:

Methylphenidate- which primarily inhibits dopamine and norepinephrine transporters.

Guanfacine instead acts directly on:

α2A adrenergic receptors

Current Canadian labeling specifically identifies guanfacine as a non-stimulant selective α2A-adrenergic receptor agonist.

How Does Guanfacine Work for ADHD?

The prefrontal cortex depends on carefully regulated norepinephrine signaling.

Appropriate stimulation of:

α2A receptors

helps support prefrontal networks involved in:

• Working memory
• Focus
• Resistance to distraction
• Behavioural inhibition
• Planning
• Impulse control Therefore:

1. Guanfacine reaches the brain
2. α2A receptors are activated
3. Prefrontal cortical signaling changes
4. Attention and executive-control networks may become more efficient
5. ADHD symptoms may improve

Guanfacine also reduces sympathetic nervous-system activity, which contributes to its effects on:

• Heart rate
• Blood pressure
• Sedation
• Physical arousal The full ADHD mechanism is more complex, and the Canadian product monograph appropriately states that the exact mechanism in ADHD remains unknown.

Which ADHD Symptoms May Guanfacine Help?

Guanfacine may help with:

• Hyperactivity- such as excessive movement or difficulty settling.

• Impulsivity- such as acting before thinking or difficulty inhibiting behaviour.

• Inattention- including difficulty staying focused or completing tasks.

• Executive control- including behavioural regulation and working memory. It may also be considered clinically when ADHD occurs together with problems such as:

• Sleep difficulty

• Tics

• Emotional dysregulation

• Excessive arousal Not all of these are separate approved indications, and the response varies considerably from person to person.

Why Is Guanfacine Sometimes Added to a Stimulant?

A stimulant and guanfacine work through different mechanisms.

Stimulant- increases dopamine and/or norepinephrine availability

while:

Guanfacine- directly stimulates α2A receptors.

Therefore, the combination may provide complementary effects.

For example:

1. Stimulant
2. Improves catecholamine availability

1. Guanfacine
2. Strengthens α2A-mediated prefrontal regulation
3. Potentially broader ADHD symptom control

Canadian Intuniv XR labeling permits adjunctive treatment with psychostimulants, and interaction studies found no meaningful pharmacokinetic effect between guanfacine and extended-release methylphenidate when studied together.

What Are the Common Side Effects of Guanfacine?

Common side effects can include:

• Sleepiness
• Sedation
• Fatigue
• Headache
• Dizziness
• Low blood pressure
• Reduced heart rate
• Nausea
• Abdominal discomfort
• Dry mouth
• Constipation
• Reduced appetite
• Insomnia in some patients Sleepiness is especially common.

In Canadian pediatric monotherapy trials, somnolence/sedation occurred in roughly 38% of children overall, while an adolescent trial reported somnolence in approximately 44%.

Side effects are often most noticeable:

• When treatment begins
• After a dose increase
• At higher exposures Some improve with continued treatment.

Why Does Guanfacine Cause Sleepiness?

Norepinephrine helps maintain:

• Alertness
• Vigilance
• Arousal
• Stress responsiveness Guanfacine stimulates alpha-2 receptors and reduces activity within some central sympathetic and arousal pathways.

Therefore:

1. Guanfacine
2. α2A receptor stimulation
3. Reduced sympathetic/noradrenergic arousal
4. Calming

but potentially:

Sleepiness and fatigue

This can sometimes be useful when ADHD is accompanied by excessive arousal or sleep difficulty, but excessive daytime sedation can interfere with:

• School
• Work
• Driving
• Concentration Patients should understand how guanfacine affects them before performing activities requiring full alertness.

Important:

Low Blood Pressure

Guanfacine was originally developed from a class of medications with blood-pressure-lowering effects.

It can cause:

Hypotension — low blood pressure

Possible symptoms include:

• Dizziness

• Lightheadedness

• Weakness

• Blurred vision

• Feeling faint The effect can be greater:

• After a dose increase

• During dehydration

• During overheating

• When combined with another blood-pressure-lowering medication Canadian labeling recommends measuring blood pressure and heart rate before starting treatment, following dose changes, periodically during treatment and after discontinuation.

Slow Heart Rate

Guanfacine can cause:

Bradycardia — reduced heart rate

Its α2A action reduces sympathetic signaling to the cardiovascular system.

Therefore:

1. α2A stimulation
2. Reduced sympathetic activity
3. Heart rate may decrease

Patients with:

• Bradycardia

• Heart block

• Previous fainting

• Arrhythmias

• Other cardiovascular disease may require additional assessment and monitoring.

• Fainting Guanfacine can occasionally cause:

Syncope — fainting

Risk can be increased by:

• Low blood pressure
• Dehydration
• Overheating
• Slow heart rate
• Standing suddenly
• Other blood-pressure-lowering medications Adequate hydration is important unless there is a medical reason to restrict fluids. Canadian labeling specifically advises avoiding dehydration and overheating.

Do Not Stop Guanfacine Suddenly

This is one of the most important safety considerations with guanfacine.

Extended-release guanfacine should generally not be stopped abruptly.

During treatment:

1. α2A receptors are continuously stimulated
2. Sympathetic activity is reduced

If guanfacine is suddenly stopped:

1. α2A stimulation disappears rapidly
2. Sympathetic activity rebounds
3. Blood pressure and heart rate may increase
4. Rebound hypertension

Rare cases of hypertensive encephalopathy have been reported after abrupt discontinuation.

Drug Interactions

Guanfacine has several clinically important interactions.

The most important metabolic pathway is:

CYP3A4 / CYP3A5

Guanfacine is a substrate of CYP3A4/5 and is primarily metabolized through CYP3A4.

Therefore, medications that inhibit or induce CYP3A4 can substantially change guanfacine exposure.

Strong or Moderate CYP3A4 Inhibitors

CYP3A4 inhibitors slow guanfacine metabolism.

Examples can include:

• Ketoconazole
• Itraconazole
• Clarithromycin
• Other moderate or strong CYP3A4 inhibitors The pathway is:

1. CYP3A4 inhibitor
2. Guanfacine metabolism slows
3. Guanfacine concentration rises
4. Possible increase in:

• Sedation
• Low blood pressure
• Slow heart rate
• Dizziness Ketoconazole increased guanfacine exposure approximately three-fold in an interaction study. Canadian labeling recommends an initial 50% guanfacine dose reduction when used with moderate or strong CYP3A4/5 inhibitors, followed by individualized titration.

Dose changes should be made by the treating healthcare professional.

Grapefruit and Grapefruit Juice

Patients taking Intuniv XR are advised to avoid: Grapefruit

Grapefruit juice

and products containing grapefruit extract.

Grapefruit can inhibit intestinal CYP3A4 and potentially increase guanfacine exposure.

The current Canadian monograph specifically recommends avoiding grapefruit products during Intuniv XR treatment.

CYP3A4 Inducers

CYP3A4 inducers can have the opposite effect.

Examples include:

• Carbamazepine
• Rifampin
• Phenytoin
• Other strong enzyme inducers The result can be:

1. CYP3A4 induction
2. Faster guanfacine metabolism
3. Lower guanfacine concentration
4. Potentially reduced ADHD benefit

Rifampin reduced guanfacine exposure by approximately 70% in a clinical interaction study.

Dose adjustment may be needed when a strong inducer is started or stopped.

Alcohol and Sedating Medications

Guanfacine can cause significant sleepiness.

Combining it with medications or substances that also cause sedation may increase:

• Sleepiness

• Dizziness

• Poor coordination

• Reduced alertness Examples include:

• Alcohol

• Benzodiazepines

• Sleep medications

• Barbiturates

• Sedating antihistamines

• Some antipsychotics Canadian labeling advises avoiding alcohol and using caution with other central nervous system depressants.

Blood Pressure Medications

Because guanfacine can reduce blood pressure, caution is appropriate when it is combined with other antihypertensive medications.

The combination may increase:

Hypotension Dizziness Fainting

Blood pressure and heart rate may require closer monitoring.

Medications That Slow Heart Rate

Examples include:

• Beta blockers

• Certain antiarrhythmics

• Verapamil

• Diltiazem

• Other heart-rate-lowering drugs Combining these with guanfacine can increase the risk of:

• Bradycardia

• Dizziness

• Fainting The Canadian monograph specifically warns about additive effects with heart-rate-lowering medications.

Valproic Acid

Guanfacine can increase concentrations of:

Valproic acid

The exact mechanism is uncertain but may involve competition for glucuronidation.

When the two medications are combined, Canadian labeling recommends considering:

• Additive CNS effects
• Valproic-acid concentration monitoring
• Dose adjustments when clinically necessary

Stimulant ADHD Medications

Guanfacine can intentionally be used with stimulant medications.

Examples include:

• Methylphenidate
• Lisdexamfetamine
• Amphetamine-based medications This combination is not automatically an interaction to avoid.

In fact, Intuniv XR is specifically approved as adjunctive treatment with psychostimulants in Canadian children and adolescents with ADHD.

Clinical monitoring remains important because stimulants and guanfacine can have different effects on:

• Blood pressure
• Heart rate
• Sleep
• Appetite

Should Guanfacine Be Taken with Food?

Intuniv XR may be taken with or without ordinary food, but:

It should not be taken with a high-fat meal.

A high-fat meal can substantially increase drug exposure.

In adults, taking Intuniv XR with a high-fat meal increased:

Peak concentration by approximately 75%

and:

Overall exposure by approximately 40%.

Higher exposure can increase adverse effects such as:

• Sedation
• Low blood pressure
• Dizziness
• Bradycardia

How Should Intuniv XR Be Taken?

Intuniv XR is an:

Extended-release tablet

It should be swallowed whole.

Do not:

• Crush it
• Chew it
• Break it Damaging the extended-release tablet can increase the rate at which guanfacine is released.

Can Guanfacine Be Taken in the Morning or at Night?

Yes.

Intuniv XR can be taken:

Once daily in the morning

or:

Once daily in the evening

depending on tolerability and the clinical plan.

Because guanfacine can cause sleepiness, evening dosing may be useful for some patients.

Others may benefit from morning dosing depending on:

• ADHD symptom timing
• Sedation
• Stimulant schedule
• Sleep pattern

Guanfacine Dosage for ADHD

Canadian treatment with Intuniv XR begins at:

1 mg once daily

The dose can be increased by:

No more than 1 mg per week

according to:

• Response
• Tolerability
• Weight
• Other medications

Canadian Guanfacine Dose for Children 6–12 Years

For monotherapy:

Maximum: 4 mg/day

The recommended target dosing range is approximately:

0.05–0.12 mg/kg/day

depending on clinical response and tolerability.

Canadian Guanfacine Dose for Adolescents 13–17 Years

For monotherapy, dosing can reach:

Up to 7 mg/day

depending on:

• Weight
• Response
• Tolerability For guanfacine used together with a psychostimulant, doses above:

4 mg/day

have not been studied in Canadian adjunctive trials and the Canadian maximum for adjunctive treatment is 4 mg/day.

Weight-Based Guanfacine Dosing

The current Canadian monograph provides the following approximate monotherapy target ranges:

Weight	Target dose range
25–33.9 kg	2–3 mg/day
34–41.4 kg	2–4 mg/day
41.5–49.4 kg	3–5 mg/day
49.5–58.4 kg	3–6 mg/day
58.5 kg or more	4–7 mg/day

The goal is generally approximately 0.05–0.12 mg/kg/day, not simply reaching the highest possible dose.

Can Extended-Release and Immediate-Release Guanfacine Be Substituted?

Not milligram-for-milligram.

Immediate-release guanfacine and Intuniv XR have different:

• Absorption
• Peak concentrations
• Time to peak concentration
• Bioavailability The Canadian product monograph therefore specifically warns:

Do not substitute immediate-release guanfacine and Intuniv XR on a milligram-for-milligram basis.

What If Guanfacine Is Missed?

If one dose is missed, patients should follow the instructions supplied for their specific product.

If:

Two or more consecutive doses are missed

the current Canadian patient information advises contacting the healthcare professional because re-titration may be necessary rather than simply restarting the previous dose.

Tapering and Stopping Guanfacine

Guanfacine should not usually be stopped abruptly.

Canadian guidance recommends reducing Intuniv XR by:

No more than 1 mg every 3–7 days

to reduce the risk of rebound increases in:

• Blood pressure
• Heart rate Blood pressure and heart rate should be monitored during and after discontinuation.

The actual taper should be individualized by the treating healthcare professional.

What Happens If Guanfacine Is Stopped Suddenly?

During treatment:

1. Guanfacine stimulates α2A receptors
2. Sympathetic activity is reduced

If treatment suddenly stops:

1. α2A stimulation falls rapidly
2. Sympathetic activity can rebound

• Heart rate rises

• Blood pressure rises Rebound hypertension may occur Symptoms can include:

• Headache

• Nervousness

• Agitation

• Tremor

• Confusion

• Rapid heart rate Very rarely, severe hypertension and hypertensive encephalopathy have been reported following abrupt discontinuation.

Frequently Asked Questions

Is Guanfacine the Same as Intuniv?

Yes.

Intuniv XR is the best-known Canadian brand name for extended-release guanfacine used to treat ADHD.

Generic extended-release guanfacine products are also available in Canada.

Is Guanfacine an ADHD Medication?

Yes.

Extended-release guanfacine is approved in Canada for ADHD in children and adolescents 6–17 years old.

Is Guanfacine a Stimulant?

No.

Guanfacine is a:

Non-stimulant α2A-adrenergic receptor agonist.

It does not work like amphetamine or methylphenidate.

Does Guanfacine Increase Norepinephrine?

Not in the same way as atomoxetine or stimulants.

Guanfacine does not primarily work by increasing the amount of norepinephrine between neurons.

Instead, it directly stimulates:

α2A adrenergic receptors

This can improve norepinephrine-related signaling within prefrontal cortical networks while also reducing sympathetic output elsewhere.

It is therefore more accurate to describe guanfacine as regulating norepinephrine signaling than simply increasing or decreasing norepinephrine.

Does Guanfacine Help Attention?

Yes, it can.

Intuniv XR is approved for ADHD and has been shown to improve overall ADHD symptoms, including inattention.

Its α2A activity is particularly relevant to the prefrontal cortex, which regulates:

• Attention
• Working memory
• Executive control
• Behavioural inhibition

Does Guanfacine Help Hyperactivity and Impulsivity?

Yes.

Guanfacine can improve:

• Hyperactivity
• Impulsivity
• Behavioural control as part of its overall ADHD effect.

Does Guanfacine Help with Emotional Regulation?

Some patients and clinicians observe improvements in emotional reactivity and behavioural regulation during ADHD treatment.

However, emotional dysregulation is not a separate approved Canadian indication for Intuniv XR.

Does Guanfacine Help with Sleep?

Guanfacine commonly causes sleepiness and is sometimes clinically useful when ADHD occurs together with difficulty settling at night.

However:

Guanfacine is not primarily a sleeping medication.

Its sedating effect must be balanced against risks such as:

• Daytime sleepiness
• Low blood pressure
• Slow heart rate

Can Guanfacine Be Taken with Vyvanse?

Yes, when prescribed appropriately.

Guanfacine can be used as adjunctive therapy with psychostimulants, including stimulant ADHD medications.

Blood pressure, heart rate, sedation and overall response should be monitored.

Can Guanfacine Be Taken with Adderall?

Yes, clinically selected patients may receive the combination.

The medications act differently: Amphetamine → increases dopamine and norepinephrine availability

while:

Guanfacine → stimulates α2A receptors.

The combination should be supervised by the prescribing clinician.

Can Guanfacine Be Taken With Methylphenidate?

Yes.

Extended-release guanfacine is approved for adjunctive use with psychostimulants, and pharmacokinetic studies did not demonstrate a meaningful interaction between guanfacine and extended-release methylphenidate at the doses studied.

Does Guanfacine Cause Weight Gain?

Weight gain can occur, but it is not generally guanfacine’s most prominent side effect.

Canadian clinical-trial data reported weight increase in a small proportion of patients.

Long-term growth and weight should still be followed as part of routine pediatric ADHD care.

Does Guanfacine Suppress Appetite?

Decreased appetite can occur, but generally it is less characteristic than with stimulant ADHD medications.

This can sometimes make guanfacine useful when stimulant-related appetite suppression is problematic, although individual response varies.

Does Guanfacine Cause Low Blood Pressure?

Yes.

Guanfacine can lower both:

Blood pressure

and:

Heart rate

which is why both should be monitored during treatment.

Why Does Guanfacine Make You Tired?

Guanfacine reduces activity in some noradrenergic and sympathetic arousal pathways.

This can produce a calming effect but also:

• Sleepiness
• Fatigue
• Sedation These effects are often most prominent early in treatment or after dose increases.

Can Guanfacine Be Taken with Grapefruit?

Canadian Intuniv XR labeling recommends avoiding grapefruit and grapefruit juice because grapefruit may inhibit CYP3A4 and increase guanfacine exposure.

Can Guanfacine Be Taken With a High-Fat Meal?

Intuniv XR should not be taken with a high-fat meal.

High-fat food substantially increases guanfacine exposure.

Does Guanfacine Need to Be Tapered?

Yes, generally.

The current Canadian monograph recommends decreasing the dose by:

No more than 1 mg every 3–7 days

because abrupt discontinuation can increase blood pressure and heart rate.

Is Guanfacine Addictive?

Guanfacine is not a stimulant and is not a controlled substance.

Current Canadian labeling notes that Intuniv XR is not a stimulant or controlled substance.

However, physical adaptation can occur, which is why it should not be abruptly discontinued.

Physical adaptation is not the same as addiction.

How Long Does Guanfacine Take to Work for ADHD?

Some effects may become apparent during the first weeks, but guanfacine is usually titrated gradually.

Because the dose generally increases by no more than 1 mg per week, it may take several weeks to determine the most effective and tolerable dose.

This differs from stimulants, where an effect may often be apparent within hours of an individual dose.

Is Guanfacine Better Than Clonidine?

Neither is universally better.

Both are alpha-2 adrenergic agonists used for ADHD.

However:

Guanfacine

is relatively more selective for:

α2A receptors

whereas:

Clonidine

has broader activity across α2A, α2B and α2C receptors.

Guanfacine’s greater α2A selectivity is one pharmacological reason it may cause less sedation and hypotension in some patients, although individual response differs.

How Is Guanfacine Different From Atomoxetine?

Both are non-stimulant ADHD medications, but they work very differently.

Atomoxetine

blocks:

1. NET — norepinephrine transporter
2. Norepinephrine availability increases in the PFC

while:

Guanfacine

stimulates:

1. α2A adrenergic receptors
2. Prefrontal norepinephrine signaling is directly modified

Atomoxetine also has an established CYP2D6 pharmacogenomic guideline.

Guanfacine currently does not have an established genotype-based dosing guideline.

Which Gene Metabolizes Guanfacine?

The principal metabolic pathway is:

CYP3A4 / CYP3A5.

Drug interactions affecting CYP3A4 can substantially change guanfacine exposure.

Does CYP3A4 Genetic Testing Determine Guanfacine Dose?

No.

There is currently no established genotype-based guanfacine dosing guideline from CPIC or DPWG.

Medication interactions with CYP3A4 currently have clearer clinical importance.

Which Gene Is Most Relevant to Guanfacine’s Brain Effect?

The most directly relevant pharmacodynamic gene is:

ADRA2A

because it encodes the:

α2A adrenergic receptor

which is guanfacine’s primary target.

However, ADRA2A testing currently does not provide a validated guanfacine dosing recommendation.

Can Pharmacogenomic Testing Tell Whether Guanfacine Will Work?

Not with certainty.

Guanfacine response can depend on:

• α2A receptor signaling
• Norepinephrine regulation
• ADHD symptom pattern
• Prefrontal cortex function
• Dose
• CYP3A4 drug interactions
• Blood pressure
• Heart rate
• Other medications
• Individual brain biology Genetic information may contribute to understanding the biology of medication response, but there is currently no validated genetic test that can guarantee guanfacine effectiveness or determine an exact dose.

References

• [https://health-products.canada.ca/dpd-bdpp/info?code=89384&lang=eng&lang=eng)
• [https://health-products.canada.ca/noc-ac/nocInfo?no=27343)
• https://pdf.hres.ca/dpd_pm/00082036.PDF
• [https://www.takeda.com/en-ca/newsroom/2019/intuniv-xr-access-improved/)